Academic Journal
The effectiveness of tyrosine kinase inhibitor for chronic myeloid leukemia in tuberous sclerosis. A case report and review of literature
Title: | The effectiveness of tyrosine kinase inhibitor for chronic myeloid leukemia in tuberous sclerosis. A case report and review of literature |
---|---|
Authors: | Abdulrahman Al‐Abdulmalek, Reem Al‐Suliman, Mohammad Abu‐Tineh, Mostafa Ali, Mohamed A. Yassin |
Source: | Clinical Case Reports, Vol 11, Iss 3, Pp n/a-n/a (2023) |
Publisher Information: | Wiley, 2023. |
Publication Year: | 2023 |
Collection: | LCC:Medicine LCC:Medicine (General) |
Subject Terms: | CML, tuberous sclerosis, tyrosine kinase inhibitors, Medicine, Medicine (General), R5-920 |
More Details: | Abstract The relationship between chronic myelogenous leukemia (CML) and tuberous sclerosis (TS) is unusual and uncommon. Here, we report a 24‐year‐old woman diagnosed with TS and later identified with CML, as the second case reported with such coexistence, treated with Nilotinib. This article proposes a hypothesis to explain the association. Therefore, we propose Nilotinib for the treatment of patients with such coexisting diseases. Further studies are warranted to reveal the dynamics between these conditions. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 2050-0904 |
Relation: | https://doaj.org/toc/2050-0904 |
DOI: | 10.1002/ccr3.7087 |
Access URL: | https://doaj.org/article/91e468329b24477c9775e1cf0bffb327 |
Accession Number: | edsdoj.91e468329b24477c9775e1cf0bffb327 |
Database: | Directory of Open Access Journals |
ISSN: | 20500904 |
---|---|
DOI: | 10.1002/ccr3.7087 |
Published in: | Clinical Case Reports |
Language: | English |